Professor of Psychiatry
Psychiatry
Dr. David L. Braff, MD
|
|
Give Review
David L. Braff, MD is an expert in the field of Psychiatry. He graduated from Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. David Braff is also a published doctor. He has 62 publication published. The most recent publication is: Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophr...
Publications
- Attention/vigilance in schizophrenia: Performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).
- Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1).
- California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: Comparing the first and second phases of the Consortium on the...
- Genomic substrates of neurophysiological endophenotypes: Where we've been and where we're going.
- Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.
- Enoch callaway.
- Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlat...
- The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2.
- Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings.
- Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medic...
- Comparison of the Heritability of Schizophrenia and Endophenotypes in the COGS-1 Family Study.
- Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS.
- Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.
- Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.
- The neuropsychiatric translational revolution: still very early and still very challenging.
- Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.
- Lack of Use in the Literature From the Last 20 Years Supports Dropping Traditional Schizophrenia Subtypes From DSM-5 and ICD-11.
- Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.
- Sex Differences in Familiality Effects on Neurocognitive Performance in Schizophrenia.
- Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.
- Disentangling early sensory information processing deficits in schizophrenia.
- Association analysis of 94 candidate genes and schizophrenia-related endophenotypes.
- Analysis of 94 Candidate Genes and 12 Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia.
- Gating in schizophrenia: from genes to cognition (to real world function?).
- Neurophysiologic markers of abnormal brain activity in schizophrenia.
- Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study.
- Electroencephalography (EEG) and event-related potentials (ERPs) with human participants.
- Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
- Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.
- Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon.
- It is time to take a stand for medical research and against terrorism targeting medical scientists.
- An event-related brain potential study of direct and indirect semantic priming in schizophrenia.
- Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia.
- Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.
- Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults.
- Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients.
- Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder.
- Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research.
- The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration.
- Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.
- Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
- Effects of background and prepulse characteristics on prepulse inhibition and facilitation: implications for neuropsychiatric research.
- Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
- Prepulse-elicited motor reactions do not differ between schizophrenia patients and control subjects.
- Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia.
- P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment.
- Female schizophrenia patients have prepulse inhibition deficits.
- Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
- The value of referring to recently introduced antipsychotics as "second generation".
- Visual masking as a probe for abnormal gamma range activity in schizophrenia.
- Schizophrenia subjects show intact success-related neural activation but impaired uncertainty processing during decision-making.
- Some possible genetic parallels across alcoholism, bipolar disorder and schizophrenia.
- Chaos and schizophrenia: does the method fit the madness?
- Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.
- Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients.
- Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?
- Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects.
- Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects.
- Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.
- Is There an Association between Advanced Paternal Age and Endophenotype Deficit Levels in Schizophrenia?
- Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophr...
Schools
Perelman School of Medicine University of Pennsylvania
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
UCSF -
Yale University School of Medicine -
California Pacific Medical Center - California Campus -
Perelman School of Medicine at the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Ronald R. Harrington, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harvey R. Forester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Li Liang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Aldous, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashok R. Parameswaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria G. Berggren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald E. Cann, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jennifer C. Nagode, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Torrente, DO
This Doctor is OpenDoctor Recommended.
|